Elis stock: UBS lifts target price to EUR 32

Published on 11/04/2026 at 03:12 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

UBS kept its Buy rating on Elis stock while lifting its valuation target. The move adds a positive broker signal ahead of the company's November investor events.

What UBS changed for Elis

UBS maintained its Buy rating while raising its valuation target for Elis.
The analyst median target stood at EUR 29.20, implying a 32.8 percent target-to-price gap in the cited market overview.
Elis has scheduled investor events in Paris, New York and London for November 2026.

Elis, FR0012435121, Illustration mit AI erstellt.

UBS raised its price target for Elis from EUR 29.40 to EUR 32.00 on October 14, 2026, while retaining its Buy rating. The change was reported by Ideal Investor in an overview of European broker revisions.

Broker view strengthens valuation case

The broker's revised target was above the median analyst target of EUR 29.20 cited in the same report. That comparison leaves UBS among the more optimistic published views on the French industrial group, although the target remains an analyst estimate rather than a company forecast.

The report also cited a 32.8 percent target-to-price gap for the median estimate. Such targets frame analysts' valuation assumptions; they do not establish a guaranteed return for shareholders.

Investor calendar points ahead

Elis lists the BNP MidCap CEO Conference in Paris for November 16, followed by the RBCCM Global Industrials Conference in New York on November 17 and the Citi Business Services, Leisure and Transport conference in London on November 23. The company's investor-relations page also lists its third-quarter 2026 revenue release dated October 28.